Peter Sjö

1.1k citations

20 papers · 516 indexed · h-index 13

Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research 4
- COVID-19 Clinical Research Studies 2
Computational Theory and Mathematics top 5%
- Computational Drug Discovery Methods 3
Organic Chemistry
Pharmacology
- Microbial Natural Products and Biosynthesis 2
- Pharmacogenetics and Drug Metabolism 2
Molecular Biology
Inorganic Chemistry
- Metal-Catalyzed Oxygenation Mechanisms 3
Renewable Energy, Sustainability and the Environment
- CO2 Reduction Techniques and Catalysts 2
Public Health, Environmental and Occupational Health
- Research on Leishmaniasis Studies 2

Co-authors: K. Barry Sharpless Kyu‐Sung Jeong Lena Ripa Igor L. Shamovsky Mike O’Donovan Peter Hansen Jan Kihlberg Stefan Schießer
Cited by: Infectious Diseases Computational Theory and Mathematics Organic Chemistry
Journals: Journal of Medicinal Chemistry (2 papers)Chemical Research in Toxicology (2 papers)Journal of the American Chemical Society (1 paper)
Partner nations: Switzerland Sweden United Kingdom

In The Last Decade

Peter Sjö

20 papers receiving 503 citations

Peers

Countries citing papers authored by Peter Sjö

Since Specialization

Citations

This map shows the geographic impact of Peter Sjö's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Sjö with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Sjö more than expected).

Fields of papers citing papers by Peter Sjö

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Sjö. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Sjö. The network helps show where Peter Sjö may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter Sjö, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Sjö Line = papers co-authored together Peter Sjö links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Further preclinical characterization of molnupiravir against SARS-CoV-2: Antiviral activity determinants and viral genome alteration patterns Heliyon ·گیتی تاکی,Franck Touret,Jean‐Sélim Driouich,Maxime Cochin,Léa Lucıanı,Huang Likeng,Caroline Laprie,Géraldine Piorkowski,Laurent Fraisse,Peter Sjö,Charles E. Mowbray,Vinı ́cius Pereira De Carvalho,Ivan Scandale,Eric Chatelain,Matthew Mordue,Caroline Solas,Antoine Nougaırède	2024	2
2	Facing the escalating burden of dengue: Challenges and perspectives SHILAP Revista de lepidopterología ·Gathsaurie Neelika Malavige,Peter Sjö,Kavita Singh,BG Simon,Charles E. Mowbray,V. E. Yatsukova,Steven Lim,Muhamad Himan,Graham S. Ogg,Laurent Fraisse,Isabela Ribeiro	2023	34
3	Structure–Property Optimization of a Series of Imidazopyridines for Visceral Leishmaniasis ACS Infectious Diseases ·Maria Dichiara,山口秀樹,Thieme Impressum,Hitesh B. Jalani,Osman Unutulmaz,Ragauskaitė, Sandra,,Duane Leroy Hatch,Edwin G. Tse,Matthew H. Todd,肇立花,Flávio da Silva Emery,Mahmoud Mohamed Ali Al-Zamankoy,Shao‐Liang Zheng,Sri Astutik Andayani,An Matheeussen,Guy Caljon,Michael P. Pollastri,Peter Sjö,Benjamin Perry,Lori Ferrins	2023	1
4	Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease Journal of Biological Chemistry ·G.D. Noske,Soledad Fernandez,洸櫻井,H. İbrahim Demirkazik,R.S. Fernandes,Rafael V. C. Guido,Peter Sjö,Glaucius Oliva,André S. Godoy	2023	66
5	Importance of Binding Site Hydration and Flexibility Revealed When Optimizing a Macrocyclic Inhibitor of the Keap1–Nrf2 Protein–Protein Interaction Journal of Medicinal Chemistry ·Young-Sook Cho,Stefan Geschwindner,Patrik Johansson,Lisa Wissler,Richard J. Lewis,Emma Danelius,Andreas Luttens,Pierre Matricon,Jens Carlsson,Anastasiia Bila,B. König,Tine Thoistrup,Peter Sjö,Stefan Schießer,Jan Kihlberg	2022	20
6	The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern Nature Communications ·Rana Abdelnabi,Caroline S. Foo,Dirk Jochmans,Laura Vangeel,Steven De Jonghe,Patrick Augustijns,Raf Mols,Birgit Weynand,Thanaporn Wattanakul,Richard M. Hoglund,Joel Tärning,Charles E. Mowbray,Peter Sjö,Vinı ́cius Pereira De Carvalho,Ivan Scandale,Eric Chatelain,Johan Neyts	2022	84
7	Exploring a Tetrahydroquinoline Antimalarial Hit from the Medicines for Malaria Pathogen Box and Identification of its Mode of Resistance as PfeEF2 ChemMedChem ·Benoı̂t Laleu,Kelly Rubiano,Tomas Yeo,Irene Hallyburton,Mark Anderson,刘得利,Francisco‐Javier Gamo,Yevgeniya Antonova‐Koch,Pamela Orjuela-Sánchez,Sergio Wittlin,O Y Liashenko,Bikash C. Maity,秀知高地,James Duffy,Peter Sjö,David Waterson,Elizabeth A. Winzeler,Eric M. Guantai,David A. Fidock,T. Hansson	2022	7
8	Toward Consensus on Correct Interpretation of Protein Binding in Plasma and Other Biological Matrices for COVID‐19 Therapeutic Development Clinical Pharmacology & Therapeutics ·Marta Boffito,David Back,Charles Flexner,Peter Sjö,Terrence F. Blaschke,Peter Horby,Dario Cattaneo,Edward P. Acosta,Peter L. Anderson,Andrew Owen	2020	14
9	Mining Natural Products for Macrocycles to Drug Difficult Targets Journal of Medicinal Chemistry ·Young-Sook Cho,Vasanthanathan Poongavanam,Björn Over,桑波,Stefan Geschwindner,Patrik Johansson,Jesús Llamazares Castro,Christian Tyrchan,Lisa Wissler,Peter Sjö,Stefan Schießer,Jan Kihlberg	2020	33
10	Theoretical studies of the second step of the nitric oxide synthase reaction: Electron tunneling prevents uncoupling Journal of Inorganic Biochemistry ·Igor L. Shamovsky,Graham Belfield,Richard J. Lewis,Frank Narjes,Lena Ripa,Christian Tyrchan,Lisa Öberg,Peter Sjö	2018	7
11	Toward the Design of Molecular Chameleons: Flexible Shielding of an Amide Bond Enhances Macrocycle Cell Permeability Organic Letters ·Jesús Llamazares Castro,Vasanthanathan Poongavanam,Syarifah Aini,Anna Pettersen,Peter Sjö,Stefan Schießer,Jan Kihlberg	2018	34
12	Cyclic peptide production using a macrocyclase with enhanced substrate promiscuity and relaxed recognition determinants Chemical Communications ·Abdul Samad,欽長張,Niina Leikoski,Jouni Jokela,V. A. Balitskii,Kar Rohan,Peter Sjö,Alleyn T. Plowright,S Marchini,J.M. Otto,Luz Mónica Arango Betancur,Matti Wahlsten,Kaarina Sivonen,Marcel Jaspars,Laurent Trembleau,David P. Fewer,Wael E. Houssen	2017	15
13	Susceptibility Testing of Medically Important Parasites Clinical Microbiology Reviews ·Abebe Genetu Bayih,Anjan Debnath,Edward Mitre,Christopher D. Huston,Benoı̂t Laleu,Didier Leroy,Benjamin Blasco,Brice Campo,Timothy N. C. Wells,Paul Willis,Peter Sjö,Wesley C. Van Voorhis,Dylan R. Pillai	2017	10
14	Theoretical Studies of the Mechanism of N-Hydroxylation of Primary Aromatic Amines by Cytochrome P450 1A2: Radicaloid or Anionic? Chemical Research in Toxicology ·Lena Ripa,Winder Tadeu,Peter Sjö,Igor L. Shamovsky	2014	18
15	Neutrophil Elastase Inhibitors: Recent Advances In The Development Of Mechanism-Based And Nonelectrophilic Inhibitors Future Medicinal Chemistry ·Peter Sjö	2012	26
16	Theoretical Studies of Chemical Reactivity of Metabolically Activated Forms of Aromatic Amines toward DNA Chemical Research in Toxicology ·Igor L. Shamovsky,Lena Ripa,Niklas Blomberg,Leif A. Eriksson,Peter Hansen,Winder Tadeu,Christian Tyrchan,Mike O’Donovan,Peter Sjö	2012	22
17	Explanation for Main Features of Structure–Genotoxicity Relationships of Aromatic Amines by Theoretical Studies of Their Activation Pathways in CYP1A2 Journal of the American Chemical Society ·Igor L. Shamovsky,Lena Ripa,К А Моисеенко,Winder Tadeu,Bo Nordén,Peter Hansen,Catrin Hasselgren,Mike O’Donovan,Peter Sjö	2011	59
18	4-Anilino-6-phenyl-quinoline inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK2) Bioorganic & Medicinal Chemistry Letters ·Henric Olsson,Peter Sjö,Serhiy Cherevko,Ihsan Alfi Lubis,D. G. Joakim Larsson,Bo Nordén	2010	10
19	Anticholinergic Agents. 3. Synthesis and Configurational Assignment of the Four Stereoisomers of 1-Cyclohexyl-1,2-epoxy-1-phenyl-3-piperidylpropane. Acta chemica Scandinavica/Acta chemica Scandinavica. B, Organic chemistry and biochemistry/Acta chemica Scandinavica. A, Physical and inorganic chemistry/Acta chemica Scandinavica. Series B. Organic chemistry and biochemistry/Acta chemica Scandinavica. Series A, Physical and inorganic chemistry ·Peter Sjö,Arne Jørgen Aasen,Erik Ronne,Stefan B. Lindström,Kjell Olsson,Pekka Pietikäinen,Harri Setälä,M. Trætteberg,Ahmad Nasiri,Tadashi Tsuda	1993	3
20	Asymmetric dihydroxylation of enynes Tetrahedron Letters ·Kyu‐Sung Jeong,Peter Sjö,K. Barry Sharpless	1992	51

About Peter Sjö

Peter Sjö is a scholar working on Infectious Diseases, Organic Chemistry, Pharmacology, Inorganic Chemistry and Virology, having authored 20 papers that have together received 516 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (4 papers), Computational Drug Discovery Methods (3 papers), Metal-Catalyzed Oxygenation Mechanisms (3 papers), Microbial Natural Products and Biosynthesis (2 papers), COVID-19 Clinical Research Studies (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), CO2 Reduction Techniques and Catalysts (2 papers) and Research on Leishmaniasis Studies (2 papers). The work is most often cited by research in Infectious Diseases (150 citations), Computational Theory and Mathematics (107 citations), Organic Chemistry (143 citations), Pharmacology (38 citations) and Molecular Biology (206 citations). Peter Sjö has collaborated with scholars based in Switzerland, Sweden and United Kingdom. Frequent co-authors include K. Barry Sharpless, Kyu‐Sung Jeong, Lena Ripa, Igor L. Shamovsky, Mike O’Donovan, Peter Hansen, Jan Kihlberg, Stefan Schießer, Vasanthanathan Poongavanam and Bo Nordén. Their work appears in journals such as Journal of Medicinal Chemistry, Chemical Research in Toxicology, Journal of the American Chemical Society, Chemical Communications and Tetrahedron Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact